IP Verse

Glaxosmithkline Llc opposition analysis

COMPANY ANALYSIS

Latest patents of Glaxosmithkline Llc opposed by its competitors

Patent:
EP2892535
Grant Date:
Sep 22, 2021
Title:
Method Of Adjuvant Cancer Treatment
Oppositions:
3
Patent:
EP3003316
Grant Date:
Jul 22, 2020
Title:
Combination Therapies For Cancer
Oppositions:
1
Patent:
EP2488033
Grant Date:
Jun 12, 2019
Title:
Combination
Oppositions:
2
Patent:
EP2925299
Grant Date:
Jun 6, 2018
Title:
Novel Pharmaceutical Composition
Oppositions:
1
Patent:
EP2124547
Grant Date:
Mar 28, 2018
Title:
Cancer Treatment Method
Oppositions:
1

Competitors of Glaxosmithkline Llc

GENERICS (UK) LTD

TEVA PHARMACEUTICAL INDUSTRIES LTD

GENERICS [UK] LIMITED

Want to track Glaxosmithkline Llc?

Feel free to send us a message here and we will get back to you